F-18 labeled PSMA inhibitor as well as preparation method and application thereof

CN119118880APending Publication Date: 2024-12-13WEST CHINA HOSPITAL SICHUAN UNIV
5 Cites 0 Cited by

Patent Information

Application Number
CN202411235980.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-04
Publication Date
2024-12-13

Smart Images

  • Figure CN119118880A_ABST
    Figure CN119118880A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of biological medicine, in particular to an F-18 labeled PSMA inhibitor as well as a preparation method and application thereof. The PSMA inhibitor realizes efficient F-18 labeling through a corresponding precursor under the catalysis of photooxidation reduction. The F-18 labeled PSMA inhibitor compound disclosed by the invention can be used as a PSMA targeted radiopharmaceutical which is better in antigen affinity and better in PSMA positive tumor imaging efficiency, and can be used for diagnosing PSMA positive tumors in nuclear medicine.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • PSMA-binding agents and uses thereof

    CN102171187A

  • 18f-labelled compound for prostate cancer diagnosis, and use thereof

    CN110770212A

  • Synthesis method of three-function diagnosis and treatment integrated prodrug for prostate cancer and product thereof

    CN113354707A

  • Method for the production of 18f-labeled active esters and their application exemplified by the preparation of a PSMA-specific pet-tracer

    WO2016030329A1

  • New scaffolds and multifunctional intermediates for imaging PSMA and cancer therapy

    WO2016065142A2